Foresite Capital Management Revenue and Competitors
Estimated Revenue & Valuation
- Foresite Capital Management's estimated annual revenue is currently $15M per year.
- Foresite Capital Management received $668.0M in venture funding in May 2018.
- Foresite Capital Management's estimated revenue per employee is $234,375
- Foresite Capital Management's total funding is $1.4B.
Employee Data
- Foresite Capital Management has 64 Employees.
- Foresite Capital Management grew their employee count by -10% last year.
Foresite Capital Management's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Head Investor Relations | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Head Research | Reveal Email/Phone |
5 | General Counsel | Reveal Email/Phone |
6 | Head Trader | Reveal Email/Phone |
7 | Managing Director | Reveal Email/Phone |
8 | Chief Financial Officer & Managing Director | Reveal Email/Phone |
9 | Managing Director | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
Foresite Capital Management Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.5M | 10 | -55% | N/A | N/A |
#2 | N/A | 35 | -3% | N/A | N/A |
#3 | $7.5M | 8 | -27% | N/A | N/A |
#4 | $3.5M | 79 | 52% | N/A | N/A |
#5 | N/A | 11 | 0% | N/A | N/A |
#6 | $7.5M | 29 | -12% | N/A | N/A |
#7 | $15M | 43 | -16% | N/A | N/A |
#8 | $15M | 34 | N/A | N/A | N/A |
#9 | $7.5M | 26 | 24% | N/A | N/A |
#10 | $15M | 245 | 18% | N/A | N/A |
What Is Foresite Capital Management?
Foresite Capital is a multi-stage healthcare and life sciences investment firm that applies rigorous scientific and data-driven approaches to investment analysis. The firm has $2.2 billion in assets under management. Foresite Capital takes a collaborative approach to investing with its portfolio companies by providing a multidisciplinary team of scientists, engineers, analysts, and clinicians who understand the unique business models in healthcare in addition to capital. The company aims to address areas of great unmet clinical need over the long term by funding promising healthcare and life sciences businesses at all stages of their life cycles. Its portfolio also emphasizes companies that are employing the tools of data science and machine intelligence in healthcare. Foresite Capital is based in San Francisco with an office in New York.
keywords:Finance,Healthcare,Pharmaceuticals
$1.4B
Total Funding
64
Number of Employees
$15M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Foresite Capital Management News
Nowadays Inc. PBC, San Francisco, $7 million: Stray Dog Capital led the seed funding ... private equity firm Foresite Capital Management.
Israeli venture capital firm Jerusalem Venture Partners argued Thursday ... action brought by investor Foresite Capital Management IV LP.
FLS XI will be led by Managing Partners Patrick Heron and James Topper and ... Foresite Capital, a multi-stage healthcare and life sciences...
US-based Foresite Capital, an investment firm that provides catalytic capital to transformative healthcare companies at all stages, raised funding totalling US$ 969 million in commitments from LPs. This is Foresite’s largest fund to date which was also oversubscribed relative to its original ta ...
Foresite Capital, a San Francisco, CA-based multi-stage healthcare and life sciences investment firm, closed its fifth fundraise with $969m in capital commitments. The offering comprises: Foresite Capital Fund V, L.P., and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresit ...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14M | 64 | 7% | $410.5M |
#2 | $8.4M | 64 | 3% | N/A |
#3 | $19M | 64 | 10% | N/A |
#4 | $15M | 64 | 19% | N/A |
#5 | $11.7M | 64 | 14% | $17.7M |
Foresite Capital Management Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-04-02 | $300.0M | Undisclosed | Article | |
| 2015-07-30 | $450.0M | Third | Article | |
| 2018-05-04 | $668.0M | Fourth | Limited partners in Fund IV | Article |